Hyphens Pharma International Limited noted the retirement of Mr. Tan Chwee Choon, a Director retiring in accordance with Regulation 97 of the Constitution of the Company, who although eligible, is not offering himself for re-election, at its AGM to be held on 26 April 2023. Mr. Tan Chwee Choon will, upon retirement, cease to be the Executive Director of the Company. Role And Responsibilities: Responsible for managing the Indochina operations.

Other DirectorShips Past: DAC Pharmalab Pte Ltd, Singapore Ocean Healthcare (M) Sdn. Bhd., Malaysia. Other DirectorShips Present: Within the Group: Hyphens Pharma Pte.

Ltd., Singapore Ocean Health Pte. Ltd., Singapore Pan-Malayan Pharmaceuticals Pte Ltd, Singapore Hyphens Pharma Philippines Inc., Philippines Subsequent to this announcement, Mr. Tan will also step down as a director of the above-mentioned Group's subsidiaries on 26 April 2023. Outside the Group: LTT Investments Pte.

Ltd., Singapore. Reason For Cessation: Tan Chwee Choon will be retiring as Director of the Company pursuant to Regulation 97 of the Constitution of the Company. Mr. Tan indicated that he would not seek for re-election as Director of the Company and would retire at the conclusion of the Annual General Meeting of the Company to be held on 26 April 2023.

Further, the Sponsor, after having interviewed Mr. Tan, is satisfied that, other than as disclosed in this announcement, there are no material reasons for the retirement of Mr. Tan as an Executive Director of the Company. The Company expresses its gratitude to Mr. Tan for his valuable contributions during his tenure of service.